查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529852

臨床試驗生物儲存庫和檔案解決方案市場規模、佔有率、趨勢分析報告：按服務、產品、階段、地區和細分市場預測，2024-2030 年

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Biorepository Services, Archiving Solution Services), By Product, By Phase, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 192 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗生物儲存庫和檔案解決方案市場成長和趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，臨床試驗生物樣本庫和歸檔解決方案的全球市場規模將達到 70 億美元，預計 2024 年至 2030 年複合年成長率為 8.17%。

這主要是由於生物樣本管理在臨床試驗中的重要性日益增加以及簡化資料收集和報告的願望。此外，精準醫學、個人化醫學和基因組醫學的擴展、研發成本的增加以及透過採用 LIMS（實驗室資訊管理系統）等實驗室樣本管理軟體來促進資料收集和報告的努力都是推動行業發展的重要因素。

多個監管機構為生物樣本庫的運作提供建議並制定最佳實踐。國際生物與環境儲存庫協會正在加強其在全球生物儲存程序標準化方面的地位。美國病理學家學會建立了第一個生物樣本庫認證計劃，該計劃遵守嚴格的法規來標準化生物樣本庫實踐。國際標準化組織 (ISO-20387) 發布了有關生物保存能力、公平性和一致操作的生物保存設施標準。

美國FDA制定了良好生產規範（GMP）、良好實驗室規範（GLP）、GDP和良好組織規範（GTP），其中包括與藥品包裝和儲存相關的要素。此外，COVID-19 大流行為當地企業創造了一些成長機會。為了鞏固在行業中的立足點，主要企業正在採取各種計劃和政策，以在全球市場上獲得更大的收益佔有率。作為重要的一步，主要企業可以與相關第三方供應商建立合作關係。這可以透過適當的溝通和調整臨床試驗生物檢體資料庫和歸檔解決方案的頻率和數量來實現。

臨床試驗生物儲存庫和檔案解決方案市場報告亮點：

  • 由於個人化醫療等先進療法的研究和開發不斷增加，並且需要高品質的生物檢體資料庫實踐來進行樣本收集、處理、測試和存儲，生物檢體資料庫服務領域將在 2022 年佔據行業主導地位。
  • 按階段來看，預計 III 期細分市場將在 2022 年佔據行業主導地位，而 II 期細分市場預計將在 2023 年至 2030 年實現最快的複合年成長率。
  • 2022 年，臨床產品領域佔據最大佔有率，因為大多數臨床試驗方案都嚴重依賴生物檢體分析來滿足試驗終點。
  • 預計亞太地區在預測期內將實現最快的成長率。臨床試驗設施從歐洲、北美等西方地區轉移到亞太地區的是推動該地區發展的主要因素。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章：臨床試驗生物儲存庫和檔案解決方案市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗生物儲存庫和檔案解決方案市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第 4 章 臨床試驗生物儲存庫和存檔解決方案市場：按服務分類的估計和趨勢分析

  • 臨床試驗生物儲存庫和檔案解決方案市場，按服務：細分儀表板
  • 臨床試驗生物儲存庫和檔案解決方案市場（按服務）：變異分析
  • 臨床試驗生物儲存庫和檔案解決方案市場（按服務）：市場估計和預測，2018-2030 年

第5章 臨床試驗生物儲存庫和檔案解決方案市場：按產品估計和趨勢分析

  • 臨床試驗生物樣本庫和檔案解決方案市場，按產品：細分儀表板
  • 臨床試驗生物樣本庫和檔案解決方案市場，副產品：變異分析
  • 臨床試驗生物樣本庫和檔案解決方案市場（按產品類型）：2018-2030 年市場估計和預測

第6章臨床試驗生物儲存庫和檔案解決方案市場：按階段估計和趨勢分析

  • 臨床試驗生物樣本庫和檔案解決方案市場，按階段：細分儀表板
  • 臨床試驗生物樣本庫和檔案解決方案市場（按階段）：變異分析
  • 臨床試驗生物樣本庫和檔案解決方案市場，按階段：市場估計和預測，2018-2030

第7章臨床試驗生物儲存庫和檔案解決方案市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 2023 年企業市場佔有率分析
  • 公司簡介
    • Medpace
    • American Type Culture Collection（ATCC）
    • Cell&Co BioServices（Cryoport）
    • Brooks Life Sciences（Azenta, Inc.）
    • Patheon（Thermo Fisher Scientific, Inc.）
    • Precision Medicine Group, LLC.
    • Labcorp Drug Development
    • Q2 Solutions
    • LabConnect
    • Charles River Laboratories
Product Code: GVR-4-68039-532-8

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends:

The global clinical trial biorepository & archiving solutions market size was valued at USD 7.0 billion in 2030 and is projected to grow at a CAGR of 8.17% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights:

  • The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
  • In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
  • The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
  • Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Product
    • 1.2.3. Phase
  • 1.3. Regional Scope
  • 1.4. Estimates And Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing number of pharmaceutical and biotechnology companies
      • 3.2.1.2. Growing disease variation and prevalence
      • 3.2.1.3. Increasing R&D investments
      • 3.2.1.4. Growth in the CRO market
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulations for new drug development
      • 3.2.2.2. Rising cost of clinical trials
  • 3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis

  • 4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
  • 4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
  • 4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
    • 4.3.1. Biorepository Services
      • 4.3.1.1. Biorepository Services Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Warehousing & storage
      • 4.3.1.2.1. Warehousing & storage Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Transportation
      • 4.3.1.3.1. Transportation Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Sample Processing
      • 4.3.1.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
      • 4.3.1.5. Others Biorepository Services
      • 4.3.1.5.1. Others Biorepository Services Market, 2018 to 2030 (USD Million)
    • 4.3.2. Archiving Solution Services
      • 4.3.2.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
      • 4.3.2.2. Database Indexing and Management
      • 4.3.2.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
      • 4.3.2.3. Scanning & Destruction
      • 4.3.2.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis

  • 5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
  • 5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
  • 5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product Type, 2018 - 2030
    • 5.3.1. Preclinical Products
      • 5.3.1.1. Preclinical Products Market, 2018 to 2030 (USD Million)
    • 5.3.2. Clinical Products
      • 5.3.2.1. Clinical Products Market, 2018 to 2030 (USD Million)
      • 5.3.2.2. Human Tissue
      • 5.3.2.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
      • 5.3.2.3. Organs
      • 5.3.2.3.1. Organs Market, 2018 to 2030 (USD Million)
      • 5.3.2.4. Stem Cells
      • 5.3.2.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
      • 5.3.2.5. Other Biospecimens
      • 5.3.2.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis

  • 6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
  • 6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
  • 6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
    • 6.3.1. Preclinical
      • 6.3.1.1. Preclinical Market, 2018 to 2030 (USD Million)
    • 6.3.2. Phase I
      • 6.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
    • 6.3.3. Phase II
      • 6.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
    • 6.3.4. Phase III
      • 6.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
    • 6.3.5. Phase IV
      • 6.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Innovators
    • 8.1.2. Market Leaders
    • 8.1.3. Emerging Players
    • 8.1.4. Company Market Share Analysis, 2023
  • 8.2. Company Profiles
    • 8.2.1. Medpace
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. American Type Culture Collection (ATCC)
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Cell&Co BioServices (Cryoport)
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Brooks Life Sciences (Azenta, Inc.)
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Patheon (Thermo Fisher Scientific, Inc.)
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Precision Medicine Group, LLC.
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Labcorp Drug Development
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Q2 Solutions
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. LabConnect
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Charles River Laboratories
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 4. North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 5. North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 6. North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 7. U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 8. U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 9. U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 10. Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 11. Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 12. Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 13. Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 14. Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 15. Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 16. Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 17. UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 18. UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 19. UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 20. Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 21. Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 22. Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 23. France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 24. France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 25. France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 26. Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 27. Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 28. Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 29. Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 30. Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 31. Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 32. Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 33. Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 34. Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 35. Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 36. Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 37. Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 38. Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 39. Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 40. Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 45. Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 46. Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 47. Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 48. China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 49. China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 50. China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 51. India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 52. India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 53. India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 54. Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 55. Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 56. Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 57. South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 58. South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 59. South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 60. Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 61. Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 62. Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 63. Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 64. Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 65. Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 66. Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 67. Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 68. Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 69. Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 70. Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 71. Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 72. Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 73. Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 74. Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 75. Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 76. Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 77. Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 78. Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 83. South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 84. South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 85. South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 89. UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 90. UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 91. UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 92. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Clinical trial biorepository & archiving solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot 1
  • Fig. 13 Segment snapshot 2
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2023 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2023 (USD Billion)
  • Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 PESTEL analysis
  • Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
  • Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
  • Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
  • Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
  • Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
  • Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
  • Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018-2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Fig. Key country dynamics
  • Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key company categorization
  • Fig. 100 Service heat map analysis
  • Fig. 101 Strategic framework